Annual ROA
-39.15%
-4.79%-13.94%
31 December 2023
Summary:
Aclaris Therapeutics annual return on assets is currently -39.15%, with the most recent change of -4.79% (-13.94%) on 31 December 2023. During the last 3 years, it has risen by +21.19% (+35.12%). ACRS annual ROA is now -79.09% below its all-time high of -21.86%, reached on 31 December 2015.ACRS ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROA
-19.82%
+9.92%+33.36%
30 September 2024
Summary:
Aclaris Therapeutics quarterly return on assets is currently -19.82%, with the most recent change of +9.92% (+33.36%) on 30 September 2024. Over the past year, it has increased by +27.71% (+58.30%). ACRS quarterly ROA is now at all-time high.ACRS Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACRS ROA Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -13.9% | +58.3% |
3 y3 years | +35.1% | +58.3% |
5 y5 years | +23.4% | +76.3% |
ACRS ROA High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -13.9% | +35.1% | at high | +58.3% |
5 y | 5 years | -13.9% | +54.6% | at high | +76.5% |
alltime | all time | -79.1% | +54.6% | at high | +76.5% |
Aclaris Therapeutics ROA History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -19.82%(-33.4%) |
June 2024 | - | -29.74%(-18.8%) |
Mar 2024 | - | -36.61%(-6.0%) |
Dec 2023 | -39.15%(+13.9%) | -38.95%(-18.1%) |
Sept 2023 | - | -47.53%(+14.2%) |
June 2023 | - | -41.61%(+8.6%) |
Mar 2023 | - | -38.31%(+12.7%) |
Dec 2022 | -34.36%(-39.1%) | -34.00%(+6.6%) |
Sept 2022 | - | -31.89%(+0.1%) |
June 2022 | - | -31.85%(-6.2%) |
Mar 2022 | - | -33.97%(-22.6%) |
Dec 2021 | -56.44%(-6.5%) | -43.90%(-7.5%) |
Sept 2021 | - | -47.47%(-9.1%) |
June 2021 | - | -52.24%(-20.9%) |
Mar 2021 | - | -66.05%(+9.5%) |
Dec 2020 | -60.34%(-30.1%) | -60.33%(+9.6%) |
Sept 2020 | - | -55.07%(-28.3%) |
June 2020 | - | -76.85%(-8.9%) |
Mar 2020 | - | -84.37%(+5.1%) |
Dec 2019 | -86.32% | -80.30%(-4.1%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2019 | - | -83.74%(+18.6%) |
June 2019 | - | -70.61%(+13.7%) |
Mar 2019 | - | -62.12%(+4.6%) |
Dec 2018 | -51.14%(+81.7%) | -59.38%(+11.9%) |
Sept 2018 | - | -53.07%(+20.0%) |
June 2018 | - | -44.24%(+15.8%) |
Mar 2018 | - | -38.21%(+18.2%) |
Dec 2017 | -28.14%(+3.1%) | -32.33%(+10.5%) |
Sept 2017 | - | -29.25%(-10.7%) |
June 2017 | - | -32.76%(-9.8%) |
Mar 2017 | - | -36.30%(-15.9%) |
Dec 2016 | -27.30%(+24.9%) | -43.17%(-5.1%) |
Sept 2016 | - | -45.47%(-12.0%) |
June 2016 | - | -51.65%(-1.8%) |
Mar 2016 | - | -52.58%(+26.5%) |
Dec 2015 | -21.86%(-55.4%) | -41.57%(-46.1%) |
Sept 2015 | - | -77.19%(+9.1%) |
June 2015 | - | -70.75%(+56.1%) |
Mar 2015 | - | -45.33%(+49.9%) |
Dec 2014 | -49.01%(+33.0%) | -30.24% |
Dec 2013 | -36.86% | - |
FAQ
- What is Aclaris Therapeutics annual return on assets?
- What is the all time high annual ROA for Aclaris Therapeutics?
- What is Aclaris Therapeutics annual ROA year-on-year change?
- What is Aclaris Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for Aclaris Therapeutics?
- What is Aclaris Therapeutics quarterly ROA year-on-year change?
What is Aclaris Therapeutics annual return on assets?
The current annual ROA of ACRS is -39.15%
What is the all time high annual ROA for Aclaris Therapeutics?
Aclaris Therapeutics all-time high annual return on assets is -21.86%
What is Aclaris Therapeutics annual ROA year-on-year change?
Over the past year, ACRS annual return on assets has changed by -4.79% (-13.94%)
What is Aclaris Therapeutics quarterly return on assets?
The current quarterly ROA of ACRS is -19.82%
What is the all time high quarterly ROA for Aclaris Therapeutics?
Aclaris Therapeutics all-time high quarterly return on assets is -19.82%
What is Aclaris Therapeutics quarterly ROA year-on-year change?
Over the past year, ACRS quarterly return on assets has changed by +27.71% (+58.30%)